Open-mkt buys · 90d
$199.7K
2 trades · 1 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$199.7K
Insiders on file
22
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Love Douglas | President & CEO | 51 | $346.7K | $820.0K | 2026-09-24 |
| Blumenkranz Mark S. | Director | 2 | $0 | $0 | 2026-08-10 |
| Cockroft Bettina M. | Director | 6 | $0 | $0 | 2026-06-11 |
| Carson William H. | Director | 25 | $374.1K | $0 | 2026-06-11 |
| Yednock Ted | EVP & Chief Scientific Officer | 49 | $0 | $1.61M | 2026-06-11 |
| Choi Jung | Director | 7 | $138.3K | $0 | 2026-06-11 |
| Waddill William D. | Director | 6 | $0 | $0 | 2026-06-11 |
| JONES WILLIAM A JR | Director | 3 | $0 | $0 | 2026-06-11 |
| Satter Muneer A | Director, 10% Owner | 22 | $43.89M | $0 | 2026-06-11 |
| ARTIS DEAN RICHARD | EVP & Chief Scientific Officer | 10 | $0 | $75.4K | 2026-03-02 |
| Overdorf Michael | EVP & Chief Business Officer | 25 | $0 | $118.3K | 2026-03-02 |
| Dananberg Jamie | Chief Medical Officer | 10 | $0 | $74.9K | 2026-03-02 |
| Lew Jennifer | EVP & Chief Financial Officer | 36 | $34.0K | $435.8K | 2026-03-02 |
| WIGGANS THOMAS G | Director | 5 | $0 | $0 | 2025-06-05 |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | 1 | $639.0K | $0 | 2023-05-25 |
| Mattheakis Larry | EVP & Chief Scientific Officer | 7 | $0 | $0 | 2022-07-11 |
| Keswani Sanjay | EVP & Chief Medical Officer | 6 | $0 | $120.5K | 2022-02-11 |
| Sun Ricky | Director | 1 | $0 | $0 | 2021-06-02 |
| Bain Capital Life Sciences Fund, L.P. | 10% Owner | 5 | $6.80M | $0 | 2020-07-28 |
| Clarus Lifesciences III, L.P. | 10% Owner | 9 | $3.40M | $0 | 2020-07-28 |
| Redmile Group, LLC | 10% Owner | 2 | $0 | $0 | 2020-07-28 |
| DEERFIELD PARTNERS, L.P. | 10% Owner | 6 | $11.90M | $0 | 2020-07-28 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Love Douglas | PRESIDENT AND CEO | P Buy | 2026-09-24 | 2026-09-25 | 26,065 | $3.83 | $99.8K | 390,476 | SEC↗ |
| Love Douglas | PRESIDENT AND CEO, Director | P Buy | 2026-09-24 | 2026-09-25 | 26,065 | $3.83 | $99.8K | 390,476 | SEC↗ |
| Blumenkranz Mark S. | Director | A Award deriv | 2026-08-10 | 2026-08-12 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Blumenkranz Mark S. | Director | A Award deriv | 2026-08-10 | 2026-08-12 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | M Exercise deriv | 2026-06-11 | 2026-06-15 | 30,646 | — | $0 | 0 | SEC↗ |
| Carson William H. | Director | A Award deriv | 2026-06-11 | 2026-06-15 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Choi Jung | Director | A Award deriv | 2026-06-11 | 2026-06-15 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Cockroft Bettina M. | Director | A Award deriv | 2026-06-11 | 2026-06-15 | 65,000 | — | $0 | 65,000 | SEC↗ |
| JONES WILLIAM A JR | Director | A Award deriv | 2026-06-11 | 2026-06-15 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Satter Muneer A | Director | A Award deriv | 2026-06-11 | 2026-06-15 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Waddill William D. | Director | A Award deriv | 2026-06-11 | 2026-06-15 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | M Exercise | 2026-06-11 | 2026-06-15 | 30,646 | $1.85 | $56.7K | 184,807 | SEC↗ |
| Satter Muneer A | Director | P Buy | 2026-05-28 | 2026-05-29 | 613,497 | $5.41 | $3.32M | 10,342,134 | SEC↗ |
| Carson William H. | Director | P Buy | 2026-05-11 | 2026-05-13 | 8,000 | $5.78 | $46.2K | 78,405 | SEC↗ |
| Carson William H. | Director | P Buy | 2026-04-10 | 2026-04-14 | 8,000 | $6.20 | $49.6K | 70,405 | SEC↗ |
| Carson William H. | Director | P Buy | 2026-03-10 | 2026-03-12 | 8,000 | $5.67 | $45.4K | 62,405 | SEC↗ |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICE | S Sale | 2026-03-02 | 2026-03-04 | 5,565 | $5.42 | $30.2K | 170,700 | SEC↗ |
| ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFIC | S Sale | 2026-03-02 | 2026-03-04 | 5,894 | $5.43 | $32.0K | 180,093 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | S Sale | 2026-03-02 | 2026-03-04 | 5,566 | $5.42 | $30.2K | 154,161 | SEC↗ |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S Sale | 2026-03-02 | 2026-03-04 | 4,339 | $5.42 | $23.5K | 182,625 | SEC↗ |
| Dananberg Jamie | CHIEF MEDICAL OFFICER | S Sale | 2026-03-02 | 2026-03-04 | 5,820 | $5.43 | $31.6K | 123,582 | SEC↗ |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICE | A Award deriv | 2026-02-19 | 2026-02-23 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | A Award deriv | 2026-02-19 | 2026-02-23 | 250,000 | — | $0 | 250,000 | SEC↗ |
| ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFIC | A Award deriv | 2026-02-19 | 2026-02-23 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | A Award deriv | 2026-02-19 | 2026-02-23 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Dananberg Jamie | CHIEF MEDICAL OFFICER | A Award deriv | 2026-02-19 | 2026-02-23 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Love Douglas | PRESIDENT AND CEO | A Award deriv | 2026-02-19 | 2026-02-23 | 1,250,000 | — | $0 | 1,250,000 | SEC↗ |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICE | A Award | 2026-02-19 | 2026-02-23 | 62,500 | — | $0 | 176,265 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | A Award | 2026-02-19 | 2026-02-23 | 62,500 | — | $0 | 159,727 | SEC↗ |
| ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFIC | A Award | 2026-02-19 | 2026-02-23 | 62,500 | — | $0 | 185,987 | SEC↗ |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | A Award | 2026-02-19 | 2026-02-23 | 62,500 | — | $0 | 186,964 | SEC↗ |
| Dananberg Jamie | CHIEF MEDICAL OFFICER | A Award | 2026-02-19 | 2026-02-23 | 56,250 | — | $0 | 129,402 | SEC↗ |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICE | S Sale | 2026-02-18 | 2026-02-20 | 7,851 | $5.11 | $40.1K | 113,765 | SEC↗ |
| Dananberg Jamie | CHIEF MEDICAL OFFICER | S Sale | 2026-02-18 | 2026-02-20 | 5,290 | $5.10 | $27.0K | 73,152 | SEC↗ |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S Sale | 2026-02-18 | 2026-02-20 | 6,225 | $5.10 | $31.7K | 124,464 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | S Sale | 2026-02-18 | 2026-02-20 | 7,857 | $5.11 | $40.1K | 97,227 | SEC↗ |
| ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFIC | S Sale | 2026-02-18 | 2026-02-20 | 5,290 | $5.10 | $27.0K | 123,487 | SEC↗ |
| Carson William H. | Director | P Buy | 2025-12-30 | 2026-01-02 | 4,115 | $5.02 | $20.7K | 54,405 | SEC↗ |
| Carson William H. | Director | P Buy | 2025-12-01 | 2025-12-03 | 4,115 | $4.47 | $18.4K | 50,290 | SEC↗ |
| Choi Jung | Director | P Buy | 2025-12-01 | 2025-12-03 | 33,000 | $4.19 | $138.3K | 33,000 | SEC↗ |
| Satter Muneer A | Director | P Buy | 2025-11-21 | 2025-11-21 | 422,613 | $4.28 | $1.81M | 9,728,637 | SEC↗ |
| Satter Muneer A | Director | P Buy | 2025-11-20 | 2025-11-21 | 400,000 | $4.48 | $1.79M | 9,306,024 | SEC↗ |
| Satter Muneer A | Director | P Buy | 2025-11-19 | 2025-11-19 | 500,000 | $3.94 | $1.97M | 8,906,024 | SEC↗ |
| Satter Muneer A | Director | P Buy | 2025-11-18 | 2025-11-19 | 500,000 | $3.18 | $1.59M | 8,406,024 | SEC↗ |
| Satter Muneer A | Director | P Buy | 2025-11-17 | 2025-11-19 | 500,000 | $2.99 | $1.50M | 7,906,024 | SEC↗ |
| Carson William H. | Director | P Buy | 2025-10-30 | 2025-10-31 | 4,115 | $3.17 | $13.0K | 46,175 | SEC↗ |
| Carson William H. | Director | P Buy | 2025-09-30 | 2025-10-02 | 4,115 | $3.05 | $12.6K | 42,060 | SEC↗ |
| Carson William H. | Director | P Buy | 2025-09-02 | 2025-09-04 | 4,115 | $2.09 | $8.6K | 37,945 | SEC↗ |
| Carson William H. | Director | P Buy | 2025-07-30 | 2025-08-01 | 4,115 | $2.43 | $10.0K | 33,830 | SEC↗ |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S Sale | 2025-07-14 | 2025-07-16 | 853 | $2.61 | $2.2K | 130,689 | SEC↗ |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICE | S Sale | 2025-07-14 | 2025-07-16 | 1,117 | $2.58 | $2.9K | 121,616 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | S Sale | 2025-07-14 | 2025-07-16 | 1,116 | $2.58 | $2.9K | 105,084 | SEC↗ |
| Carson William H. | Director | P Buy | 2025-06-30 | 2025-07-01 | 4,115 | $2.46 | $10.1K | 29,715 | SEC↗ |
| Cockroft Bettina M. | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 55,000 | — | $0 | 55,000 | SEC↗ |
| JONES WILLIAM A JR | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Choi Jung | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Carson William H. | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Waddill William D. | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | A Award deriv | 2025-06-05 | 2025-06-09 | 55,000 | — | $0 | 55,000 | SEC↗ |
| WIGGANS THOMAS G | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | A Award deriv | 2025-02-27 | 2025-03-03 | 272,575 | — | $0 | 272,575 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | A Award deriv | 2025-02-27 | 2025-03-03 | 272,575 | — | $0 | 272,575 | SEC↗ |
| Love Douglas | PRESIDENT AND CEO | A Award deriv | 2025-02-27 | 2025-03-03 | 1,300,000 | — | $0 | 1,300,000 | SEC↗ |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICE | A Award deriv | 2025-02-27 | 2025-03-03 | 272,575 | — | $0 | 272,575 | SEC↗ |
| Dananberg Jamie | CHIEF MEDICAL OFFICER | A Award deriv | 2025-02-27 | 2025-03-03 | 228,225 | — | $0 | 228,225 | SEC↗ |
| ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFIC | A Award deriv | 2025-02-27 | 2025-03-03 | 272,575 | — | $0 | 272,575 | SEC↗ |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICE | S Sale | 2025-02-18 | 2025-02-20 | 6,912 | $2.92 | $20.2K | 77,770 | SEC↗ |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S Sale | 2025-02-18 | 2025-02-20 | 6,618 | $2.95 | $19.5K | 86,579 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | S Sale | 2025-02-18 | 2025-02-20 | 8,345 | $2.91 | $24.3K | 61,237 | SEC↗ |
| ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFIC | S Sale | 2025-02-18 | 2025-02-20 | 5,515 | $2.97 | $16.4K | 83,814 | SEC↗ |
| Dananberg Jamie | CHIEF MEDICAL OFFICER | S Sale | 2025-02-18 | 2025-02-20 | 5,521 | $2.96 | $16.3K | 33,479 | SEC↗ |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S Sale | 2025-02-13 | 2025-02-18 | 1,425 | $2.99 | $4.3K | 93,197 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | S Sale | 2025-02-13 | 2025-02-18 | 1,783 | $2.99 | $5.3K | 69,582 | SEC↗ |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICE | S Sale | 2025-02-13 | 2025-02-18 | 1,786 | $2.98 | $5.3K | 84,682 | SEC↗ |
| Love Douglas | PRESIDENT AND CEO | S Sale | 2025-02-13 | 2025-02-18 | 5,021 | $2.95 | $14.8K | 351,554 | SEC↗ |
| JONES WILLIAM A JR | Director | A Award deriv | 2025-01-09 | 2025-01-10 | 88,000 | — | $0 | 88,000 | SEC↗ |
| Love Douglas | PRESIDENT AND CEO | M Exercise deriv | 2025-01-06 | 2025-01-08 | 37,994 | — | $0 | 0 | SEC↗ |
| Love Douglas | PRESIDENT AND CEO | M Exercise | 2025-01-06 | 2025-01-08 | 37,994 | $1.41 | $53.6K | 356,575 | SEC↗ |
| Carson William H. | Director | P Buy | 2024-12-02 | 2024-12-04 | 3,200 | $5.33 | $17.1K | 25,600 | SEC↗ |
| Love Douglas | PRESIDENT AND CEO | M Exercise deriv | 2024-10-30 | 2024-11-01 | 78,399 | — | $0 | 0 | SEC↗ |
| Love Douglas | PRESIDENT AND CEO | M Exercise deriv | 2024-10-30 | 2024-11-01 | 36,050 | — | $0 | 0 | SEC↗ |
| Love Douglas | PRESIDENT AND CEO | M Exercise | 2024-10-30 | 2024-11-01 | 36,050 | $1.85 | $66.7K | 310,570 | SEC↗ |
| Love Douglas | PRESIDENT AND CEO | M Exercise | 2024-10-30 | 2024-11-01 | 78,399 | $1.85 | $145.0K | 274,520 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | M Exercise deriv | 2024-10-15 | 2024-10-17 | 5,408 | — | $0 | 30,646 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | S Sale | 2024-10-15 | 2024-10-17 | 5,408 | $7.41 | $40.1K | 71,365 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | M Exercise | 2024-10-15 | 2024-10-17 | 5,408 | $1.85 | $10.0K | 76,773 | SEC↗ |
| Carson William H. | Director | P Buy | 2024-10-01 | 2024-10-02 | 3,200 | $5.97 | $19.1K | 22,400 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | S Sale | 2024-09-19 | 2024-09-20 | 4,500 | $7.10 | $31.9K | 0 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | S Sale | 2024-09-12 | 2024-09-16 | 5,500 | $6.16 | $33.9K | 4,500 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | S Sale | 2024-09-05 | 2024-09-06 | 5,500 | $5.64 | $31.0K | 10,000 | SEC↗ |
| Carson William H. | Director | P Buy | 2024-09-03 | 2024-09-04 | 3,200 | $5.48 | $17.5K | 19,200 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | S Sale | 2024-08-29 | 2024-08-30 | 5,500 | $5.95 | $32.7K | 15,500 | SEC↗ |
| Carson William H. | Director | P Buy | 2024-08-01 | 2024-08-05 | 3,200 | $6.24 | $20.0K | 16,000 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | S Sale | 2024-07-15 | 2024-07-17 | 1,106 | $6.02 | $6.7K | 71,365 | SEC↗ |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICE | S Sale | 2024-07-15 | 2024-07-17 | 1,104 | $6.03 | $6.7K | 86,468 | SEC↗ |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S Sale | 2024-07-15 | 2024-07-17 | 784 | $6.02 | $4.7K | 94,622 | SEC↗ |
| Carson William H. | Director | P Buy | 2024-07-01 | 2024-07-02 | 3,200 | $5.00 | $16.0K | 12,800 | SEC↗ |
| Cockroft Bettina M. | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 44,000 | — | $0 | 44,000 | SEC↗ |
| Carson William H. | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 44,000 | — | $0 | 44,000 | SEC↗ |
| Waddill William D. | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 44,000 | — | $0 | 44,000 | SEC↗ |
| Choi Jung | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 44,000 | — | $0 | 44,000 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | A Award deriv | 2024-06-05 | 2024-06-07 | 44,000 | — | $0 | 44,000 | SEC↗ |
| WIGGANS THOMAS G | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 44,000 | — | $0 | 44,000 | SEC↗ |
| Carson William H. | Director | P Buy | 2024-06-03 | 2024-06-05 | 3,200 | $4.83 | $15.5K | 9,600 | SEC↗ |
| Carson William H. | Director | P Buy | 2024-05-01 | 2024-05-03 | 3,200 | $4.68 | $15.0K | 6,400 | SEC↗ |
| Carson William H. | Director | P Buy | 2024-04-08 | 2024-04-10 | 3,200 | $6.07 | $19.4K | 3,200 | SEC↗ |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | A Award | 2024-02-27 | 2025-03-03 | 44,963 | — | $0 | 131,542 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | A Award | 2024-02-27 | 2025-03-03 | 44,963 | — | $0 | 106,200 | SEC↗ |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICE | A Award | 2024-02-27 | 2025-03-03 | 44,963 | — | $0 | 122,733 | SEC↗ |
| Dananberg Jamie | CHIEF MEDICAL OFFICER | A Award | 2024-02-27 | 2025-03-03 | 44,963 | — | $0 | 78,442 | SEC↗ |
| ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFIC | A Award | 2024-02-27 | 2025-03-03 | 44,963 | — | $0 | 128,777 | SEC↗ |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICE | S Sale | 2024-02-20 | 2024-02-21 | 2,593 | $5.53 | $14.3K | 82,058 | SEC↗ |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S Sale | 2024-02-20 | 2024-02-21 | 1,951 | $5.48 | $10.7K | 85,641 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | S Sale | 2024-02-20 | 2024-02-21 | 2,604 | $5.51 | $14.3K | 72,471 | SEC↗ |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICE | A Award deriv | 2024-02-16 | 2024-02-21 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | A Award deriv | 2024-02-16 | 2024-02-21 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | A Award deriv | 2024-02-16 | 2024-02-21 | 160,000 | — | $0 | 160,000 | SEC↗ |
| ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFIC | A Award deriv | 2024-02-16 | 2024-02-21 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Dananberg Jamie | CHIEF MEDICAL OFFICER | A Award deriv | 2024-02-16 | 2024-02-21 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Love Douglas | PRESIDENT AND CEO | A Award deriv | 2024-02-16 | 2024-02-21 | 656,200 | — | $0 | 656,200 | SEC↗ |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICE | A Award | 2024-02-16 | 2024-02-21 | 39,000 | — | $0 | 84,651 | SEC↗ |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | A Award | 2024-02-16 | 2024-02-21 | 39,000 | — | $0 | 87,592 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | A Award | 2024-02-16 | 2024-02-21 | 39,000 | — | $0 | 75,075 | SEC↗ |
| ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFIC | A Award | 2024-02-16 | 2024-02-21 | 39,000 | — | $0 | 89,329 | SEC↗ |
| Dananberg Jamie | CHIEF MEDICAL OFFICER | A Award | 2024-02-16 | 2024-02-21 | 39,000 | — | $0 | 39,000 | SEC↗ |
| Yednock Ted | EVP & CHIEF INNOVATION OFFIC | S Sale | 2024-02-12 | 2024-02-14 | 1,810 | $5.54 | $10.0K | 36,075 | SEC↗ |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICE | S Sale | 2024-02-12 | 2024-02-14 | 1,809 | $5.54 | $10.0K | 45,651 | SEC↗ |
| Love Douglas | PRESIDENT AND CEO | S Sale | 2024-02-12 | 2024-02-14 | 5,782 | $5.54 | $32.0K | 196,121 | SEC↗ |
| Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S Sale | 2024-02-12 | 2024-02-14 | 1,349 | $5.53 | $7.5K | 48,592 | SEC↗ |
| Yednock Ted | EVP & Chief Innovation Offic | M Exercise | 2023-12-27 | 2024-01-23 | 10,615 | $1.41 | $15.0K | 48,500 | SEC↗ |
| Yednock Ted | EVP & Chief Innovation Offic | M Exercise | 2023-12-27 | 2024-01-23 | 10,385 | $1.85 | $19.2K | 58,885 | SEC↗ |
| Yednock Ted | EVP & Chief Innovation Offic | S Sale | 2023-12-27 | 2024-01-23 | 21,000 | $4.52 | $94.9K | 37,885 | SEC↗ |
| Yednock Ted | EVP & Chief Innovation Offic | M Exercise deriv | 2023-12-27 | 2023-12-29 | 10,615 | — | $0 | 0 | SEC↗ |
| Yednock Ted | EVP & Chief Innovation Offic | M Exercise deriv | 2023-12-27 | 2023-12-29 | 10,385 | — | $0 | 36,000 | SEC↗ |
| Yednock Ted | EVP & Chief Innovation Offic | M Exercise | 2023-12-27 | 2023-12-29 | 10,615 | $1.41 | $15.0K | 10,615 | SEC↗ |
| Yednock Ted | EVP & Chief Innovation Offic | S Sale | 2023-12-27 | 2023-12-29 | 21,000 | $4.52 | $94.9K | 0 | SEC↗ |
| Yednock Ted | EVP & Chief Innovation Offic | M Exercise | 2023-12-27 | 2023-12-29 | 10,385 | $1.85 | $19.2K | 21,000 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2023-12-26 | 2023-12-28 | 350,000 | $2.88 | $1.01M | 7,406,024 | SEC↗ |
| Dananberg Jamie | Chief Medical Officer | A Award deriv | 2023-08-01 | 2023-08-02 | 275,000 | — | $0 | 275,000 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | S Sale | 2023-07-11 | 2024-01-23 | 1,057 | $3.84 | $4.1K | 47,460 | SEC↗ |
| Overdorf Michael | EVP & Chief Business Officer | S Sale | 2023-07-11 | 2024-01-23 | 978 | $3.84 | $3.8K | 45,802 | SEC↗ |
| Yednock Ted | EVP & Chief Innovation Offic | S Sale | 2023-07-11 | 2024-01-23 | 1,057 | $3.84 | $4.1K | 37,885 | SEC↗ |
| Carson William H. | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Waddill William D. | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Cockroft Bettina M. | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Choi Jung | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 24,000 | — | $0 | 24,000 | SEC↗ |
| WIGGANS THOMAS G | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | A Award deriv | 2023-06-08 | 2023-06-12 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Bain Capital Life Sciences Inv | 10% Owner | P Buy | 2023-05-25 | 2023-05-30 | 300,000 | $2.13 | $639.0K | 5,701,926 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | A Award deriv | 2023-02-16 | 2023-02-21 | 77,050 | — | $0 | 77,050 | SEC↗ |
| Overdorf Michael | EVP & Chief Business Officer | A Award deriv | 2023-02-16 | 2023-02-21 | 77,050 | — | $0 | 77,050 | SEC↗ |
| Love Douglas | President & CEO | A Award deriv | 2023-02-16 | 2023-02-21 | 345,000 | — | $0 | 345,000 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | A Award | 2023-02-16 | 2023-02-21 | 18,975 | — | $0 | 48,517 | SEC↗ |
| Overdorf Michael | EVP & Chief Business Officer | A Award | 2023-02-16 | 2023-02-21 | 18,975 | — | $0 | 46,780 | SEC↗ |
| Love Douglas | President & CEO | S Sale | 2023-02-15 | 2023-02-17 | 6,571 | $5.87 | $38.6K | 197,646 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | S Sale | 2023-02-14 | 2023-02-15 | 166 | $6.30 | $1.0K | 29,542 | SEC↗ |
| Overdorf Michael | EVP & Chief Business Officer | S Sale | 2023-02-14 | 2023-02-15 | 144 | $6.30 | $907 | 27,805 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | S Sale | 2023-02-13 | 2023-02-15 | 1,742 | $6.31 | $11.0K | 29,708 | SEC↗ |
| Overdorf Michael | EVP & Chief Business Officer | S Sale | 2023-02-13 | 2023-02-15 | 1,501 | $6.30 | $9.5K | 27,949 | SEC↗ |
| Satter Muneer A | Director, 10% Owner | P Buy | 2023-02-10 | 2023-02-14 | 2,647,058 | $6.80 | $18.00M | 7,056,024 | SEC↗ |
| ARTIS DEAN RICHARD | EVP & Chief Scientific Offic | A Award deriv | 2023-01-15 | 2023-01-18 | 210,000 | — | $0 | 210,000 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | A Award deriv | 2022-07-11 | 2022-07-13 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Love Douglas | President & CEO | A Award deriv | 2022-07-11 | 2022-07-13 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Love Douglas | President & CEO | A Award deriv | 2022-07-11 | 2022-07-13 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Mattheakis Larry | EVP & Chief Scientific Offic | A Award deriv | 2022-07-11 | 2022-07-13 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Mattheakis Larry | EVP & Chief Scientific Offic | A Award deriv | 2022-07-11 | 2022-07-13 | 37,500 | — | $0 | 37,500 | SEC↗ |
| Love Douglas | President & CEO | A Award deriv | 2022-07-11 | 2022-07-13 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Overdorf Michael | EVP & Chief Business Officer | A Award deriv | 2022-07-11 | 2022-07-13 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | A Award | 2022-07-11 | 2022-07-13 | 9,375 | — | $0 | 23,875 | SEC↗ |
| Mattheakis Larry | EVP & Chief Scientific Offic | A Award | 2022-07-11 | 2022-07-13 | 4,688 | — | $0 | 17,188 | SEC↗ |
| Mattheakis Larry | EVP & Chief Scientific Offic | A Award | 2022-07-11 | 2022-07-13 | 4,688 | — | $0 | 17,188 | SEC↗ |
| Overdorf Michael | EVP & Chief Business Officer | A Award | 2022-07-11 | 2022-07-13 | 9,375 | — | $0 | 21,875 | SEC↗ |
| Satter Muneer A | Director | P Buy deriv | 2022-07-07 | 2022-07-11 | 613,497 | $0.13 | $79.8K | 613,497 | SEC↗ |
| Satter Muneer A | Director | P Buy | 2022-07-07 | 2022-07-11 | 2,453,988 | $3.84 | $9.42M | 4,408,966 | SEC↗ |
| Carson William H. | Director | A Award deriv | 2022-06-09 | 2022-06-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Choi Jung | Director | A Award deriv | 2022-06-09 | 2022-06-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Cockroft Bettina M. | Director | A Award deriv | 2022-06-09 | 2022-06-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Satter Muneer A | Director | A Award deriv | 2022-06-09 | 2022-06-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Waddill William D. | Director | A Award deriv | 2022-06-09 | 2022-06-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| WIGGANS THOMAS G | Director | A Award deriv | 2022-06-09 | 2022-06-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Love Douglas | President & CEO | P Buy | 2022-04-14 | 2022-04-18 | 60,000 | $2.45 | $147.0K | 200,942 | SEC↗ |
| Mattheakis Larry | EVP & Chief Scientific Offic | A Award deriv | 2022-02-11 | 2022-02-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | A Award deriv | 2022-02-11 | 2022-02-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Keswani Sanjay | EVP & Chief Medical Officer | A Award deriv | 2022-02-11 | 2022-02-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Overdorf Michael | EVP & Chief Business Officer | A Award deriv | 2022-02-11 | 2022-02-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Love Douglas | President & CEO | A Award deriv | 2022-02-11 | 2022-02-15 | 320,000 | — | $0 | 320,000 | SEC↗ |
| Mattheakis Larry | EVP & Chief Scientific Offic | A Award | 2022-02-11 | 2022-02-15 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | A Award | 2022-02-11 | 2022-02-15 | 12,500 | — | $0 | 14,500 | SEC↗ |
| Keswani Sanjay | EVP & Chief Medical Officer | A Award | 2022-02-11 | 2022-02-15 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Overdorf Michael | EVP & Chief Business Officer | A Award | 2022-02-11 | 2022-02-15 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Love Douglas | President & CEO | A Award | 2022-02-11 | 2022-02-15 | 40,000 | — | $0 | 140,942 | SEC↗ |
| Cockroft Bettina M. | Director | A Award deriv | 2022-01-19 | 2022-01-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Love Douglas | President & CEO | M Exercise deriv | 2021-11-11 | 2021-11-15 | 30,000 | — | $0 | 114,449 | SEC↗ |
| Love Douglas | President & CEO | M Exercise deriv | 2021-11-11 | 2021-11-15 | 70,942 | — | $0 | 0 | SEC↗ |
| Love Douglas | President & CEO | M Exercise | 2021-11-11 | 2021-11-15 | 70,942 | $1.41 | $100.0K | 70,942 | SEC↗ |
| Love Douglas | President & CEO | M Exercise | 2021-11-11 | 2021-11-15 | 30,000 | $1.85 | $55.5K | 100,942 | SEC↗ |
| Mattheakis Larry | Chief Scientific Officer | A Award deriv | 2021-09-30 | 2021-10-04 | 220,000 | — | $0 | 220,000 | SEC↗ |
| Love Douglas | President & CEO | M Exercise deriv | 2021-09-16 | 2021-09-20 | 7,500 | — | $0 | 37,994 | SEC↗ |
| Love Douglas | President & CEO | S Sale | 2021-09-16 | 2021-09-20 | 7,500 | $22.05 | $165.4K | 0 | SEC↗ |
| Love Douglas | President & CEO | M Exercise | 2021-09-16 | 2021-09-20 | 7,500 | $1.41 | $10.6K | 7,500 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | M Exercise deriv | 2021-09-13 | 2021-09-15 | 3,500 | — | $0 | 143,793 | SEC↗ |
| Yednock Ted | EVP & Chief Scientific Offic | M Exercise deriv | 2021-09-13 | 2021-09-15 | 1,190 | — | $0 | 67,939 | SEC↗ |
| Yednock Ted | EVP & Chief Scientific Offic | M Exercise deriv | 2021-09-13 | 2021-09-15 | 15,000 | — | $0 | 10,615 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | M Exercise | 2021-09-13 | 2021-09-15 | 3,500 | $7.49 | $26.2K | 5,500 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | S Sale | 2021-09-13 | 2021-09-15 | 3,500 | $20.01 | $70.0K | 2,000 | SEC↗ |
| Yednock Ted | EVP & Chief Scientific Offic | M Exercise | 2021-09-13 | 2021-09-15 | 15,000 | $1.41 | $21.1K | 15,000 | SEC↗ |
| Yednock Ted | EVP & Chief Scientific Offic | M Exercise | 2021-09-13 | 2021-09-15 | 1,190 | $5.11 | $6.1K | 16,190 | SEC↗ |
| Yednock Ted | EVP & Chief Scientific Offic | S Sale | 2021-09-13 | 2021-09-15 | 16,190 | $20.00 | $323.8K | 0 | SEC↗ |
| Waddill William D. | Director | A Award deriv | 2021-08-12 | 2021-08-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Love Douglas | President & CEO | M Exercise deriv | 2021-06-08 | 2021-06-09 | 3,750 | — | $0 | 45,494 | SEC↗ |
| Love Douglas | President & CEO | S Sale | 2021-06-08 | 2021-06-09 | 3,750 | $22.55 | $84.6K | 0 | SEC↗ |
| Love Douglas | President & CEO | M Exercise | 2021-06-08 | 2021-06-09 | 3,750 | $1.41 | $5.3K | 3,750 | SEC↗ |
| Love Douglas | President & CEO | M Exercise deriv | 2021-06-07 | 2021-06-09 | 3,750 | — | $0 | 49,244 | SEC↗ |
| Love Douglas | President & CEO | S Sale | 2021-06-07 | 2021-06-09 | 3,750 | $22.31 | $83.7K | 0 | SEC↗ |
| Love Douglas | President & CEO | M Exercise | 2021-06-07 | 2021-06-09 | 3,750 | $1.41 | $5.3K | 3,750 | SEC↗ |
| Yednock Ted | EVP & Chief Scientific Offic | M Exercise deriv | 2021-06-03 | 2021-06-07 | 15,000 | — | $0 | 25,615 | SEC↗ |
| Yednock Ted | EVP & Chief Scientific Offic | S Sale | 2021-06-03 | 2021-06-07 | 2,184 | $21.72 | $47.4K | 0 | SEC↗ |
| Yednock Ted | EVP & Chief Scientific Offic | M Exercise | 2021-06-03 | 2021-06-07 | 15,000 | $1.41 | $21.1K | 15,000 | SEC↗ |
| Yednock Ted | EVP & Chief Scientific Offic | S Sale | 2021-06-03 | 2021-06-07 | 12,816 | $21.45 | $274.9K | 2,184 | SEC↗ |
| Sun Ricky | Director | A Award deriv | 2021-06-02 | 2021-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Carson William H. | Director | A Award deriv | 2021-06-02 | 2021-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Choi Jung | Director | A Award deriv | 2021-06-02 | 2021-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| WIGGANS THOMAS G | Director | A Award deriv | 2021-06-02 | 2021-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Satter Muneer A | Director | A Award deriv | 2021-06-02 | 2021-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | M Exercise deriv | 2021-05-27 | 2021-06-01 | 3,500 | — | $0 | 147,293 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | M Exercise | 2021-05-27 | 2021-06-01 | 3,500 | $7.49 | $26.2K | 5,500 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | S Sale | 2021-05-27 | 2021-06-01 | 3,500 | $22.24 | $77.8K | 2,000 | SEC↗ |
| Love Douglas | President & CEO | M Exercise deriv | 2021-04-01 | 2021-04-02 | 500 | — | $0 | 52,994 | SEC↗ |
| Love Douglas | President & CEO | S Sale | 2021-04-01 | 2021-04-02 | 300 | $28.01 | $8.4K | 0 | SEC↗ |
| Love Douglas | President & CEO | M Exercise | 2021-04-01 | 2021-04-02 | 500 | $1.41 | $705 | 500 | SEC↗ |
| Love Douglas | President & CEO | S Sale | 2021-04-01 | 2021-04-02 | 200 | $28.19 | $5.6K | 300 | SEC↗ |
| Love Douglas | President & CEO | M Exercise deriv | 2021-03-31 | 2021-04-02 | 7,102 | — | $0 | 53,494 | SEC↗ |
| Love Douglas | President & CEO | M Exercise | 2021-03-31 | 2021-04-02 | 7,102 | $1.41 | $10.0K | 7,102 | SEC↗ |
| Love Douglas | President & CEO | S Sale | 2021-03-31 | 2021-04-02 | 7,102 | $28.11 | $199.6K | 0 | SEC↗ |
| Love Douglas | President & CEO | M Exercise deriv | 2021-03-30 | 2021-03-31 | 3,750 | — | $0 | 60,596 | SEC↗ |
| Love Douglas | President & CEO | M Exercise | 2021-03-30 | 2021-03-31 | 3,750 | $1.41 | $5.3K | 3,750 | SEC↗ |
| Love Douglas | President & CEO | S Sale | 2021-03-30 | 2021-03-31 | 1,900 | $24.27 | $46.1K | 1,850 | SEC↗ |
| Love Douglas | President & CEO | S Sale | 2021-03-30 | 2021-03-31 | 1,850 | $24.78 | $45.8K | 0 | SEC↗ |
| Love Douglas | President & CEO | M Exercise deriv | 2021-03-29 | 2021-03-31 | 3,750 | — | $0 | 64,346 | SEC↗ |
| Love Douglas | President & CEO | S Sale | 2021-03-29 | 2021-03-31 | 300 | $27.24 | $8.2K | 0 | SEC↗ |
| Love Douglas | President & CEO | S Sale | 2021-03-29 | 2021-03-31 | 600 | $26.42 | $15.9K | 300 | SEC↗ |
| Love Douglas | President & CEO | M Exercise | 2021-03-29 | 2021-03-31 | 3,750 | $1.41 | $5.3K | 3,750 | SEC↗ |
| Love Douglas | President & CEO | S Sale | 2021-03-29 | 2021-03-31 | 2,850 | $25.02 | $71.3K | 900 | SEC↗ |
| Yednock Ted | EVP & Chief Scientific Offic | M Exercise deriv | 2021-03-25 | 2021-03-29 | 1,175 | — | $0 | 69,129 | SEC↗ |
| Yednock Ted | EVP & Chief Scientific Offic | M Exercise deriv | 2021-03-25 | 2021-03-29 | 15,000 | — | $0 | 40,615 | SEC↗ |
| Yednock Ted | EVP & Chief Scientific Offic | S Sale | 2021-03-25 | 2021-03-29 | 5,680 | $29.21 | $165.9K | 237 | SEC↗ |
| Yednock Ted | EVP & Chief Scientific Offic | S Sale | 2021-03-25 | 2021-03-29 | 237 | $29.96 | $7.1K | 0 | SEC↗ |
| Yednock Ted | EVP & Chief Scientific Offic | S Sale | 2021-03-25 | 2021-03-29 | 10,258 | $28.54 | $292.8K | 5,917 | SEC↗ |
| Yednock Ted | EVP & Chief Scientific Offic | M Exercise | 2021-03-25 | 2021-03-29 | 1,175 | $5.11 | $6.0K | 16,175 | SEC↗ |
| Yednock Ted | EVP & Chief Scientific Offic | M Exercise | 2021-03-25 | 2021-03-29 | 15,000 | $1.41 | $21.1K | 15,000 | SEC↗ |
| Keswani Sanjay | EVP & Chief Medical Officer | M Exercise deriv | 2021-03-24 | 2021-03-26 | 3,995 | — | $0 | 182,956 | SEC↗ |
| Keswani Sanjay | EVP & Chief Medical Officer | S Sale | 2021-03-24 | 2021-03-26 | 3,995 | $30.17 | $120.5K | 0 | SEC↗ |
| Keswani Sanjay | EVP & Chief Medical Officer | M Exercise | 2021-03-24 | 2021-03-26 | 3,995 | $7.49 | $29.9K | 3,995 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | M Exercise deriv | 2021-03-23 | 2021-03-25 | 5,000 | — | $0 | 150,793 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | S Sale | 2021-03-23 | 2021-03-25 | 1,800 | $28.43 | $51.2K | 3,800 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | S Sale | 2021-03-23 | 2021-03-25 | 1,800 | $29.16 | $52.5K | 2,000 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | M Exercise | 2021-03-23 | 2021-03-25 | 5,000 | $7.49 | $37.5K | 7,000 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | S Sale | 2021-03-23 | 2021-03-25 | 1,400 | $27.51 | $38.5K | 5,600 | SEC↗ |
| Love Douglas | President & CEO | A Award deriv | 2021-02-25 | 2021-03-01 | 325,000 | — | $0 | 325,000 | SEC↗ |
| Overdorf Michael | EVP & Chief Business Officer | A Award deriv | 2021-02-25 | 2021-03-01 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | A Award deriv | 2021-02-25 | 2021-03-01 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Yednock Ted | EVP & Chief Scientific Offic | A Award deriv | 2021-02-25 | 2021-03-01 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Keswani Sanjay | EVP & Chief Medical Officer | A Award deriv | 2021-02-25 | 2021-03-01 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Carson William H. | Director | A Award deriv | 2021-02-05 | 2021-02-08 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DEERFIELD PARTNERS, L.P. | 10% Owner | C Conversion deriv | 2020-07-28 | 2020-07-28 | 4,043,032 | — | $0 | 0 | SEC↗ |
| DEERFIELD PARTNERS, L.P. | 10% Owner | C Conversion deriv | 2020-07-28 | 2020-07-28 | 4,043,031 | — | $0 | 0 | SEC↗ |
| Satter Muneer A | Director | C Conversion deriv | 2020-07-28 | 2020-07-28 | 2,812,543 | — | $0 | 0 | SEC↗ |
| Satter Muneer A | Director | C Conversion deriv | 2020-07-28 | 2020-07-28 | 5,537,036 | — | $0 | 0 | SEC↗ |
| Satter Muneer A | Director | C Conversion deriv | 2020-07-28 | 2020-07-28 | 4,016,573 | — | $0 | 0 | SEC↗ |
| Satter Muneer A | Director | C Conversion deriv | 2020-07-28 | 2020-07-28 | 3,095,238 | — | $0 | 0 | SEC↗ |
| Bain Capital Life Sciences Fun | 10% Owner | C Conversion deriv | 2020-07-28 | 2020-07-28 | 22,222,221 | — | $0 | 0 | SEC↗ |
| Bain Capital Life Sciences Fun | 10% Owner | C Conversion deriv | 2020-07-28 | 2020-07-28 | 2,812,543 | — | $0 | 0 | SEC↗ |
| Redmile Group, LLC | 10% Owner | C Conversion deriv | 2020-07-28 | 2020-07-30 | 14,062,719 | — | $0 | 0 | SEC↗ |
| Clarus Lifesciences III, L.P. | 10% Owner | C Conversion deriv | 2020-07-28 | 2020-07-30 | 8,370,685 | — | $0 | 0 | SEC↗ |
| Clarus Lifesciences III, L.P. | 10% Owner | C Conversion deriv | 2020-07-28 | 2020-07-30 | 6,148,147 | — | $0 | 0 | SEC↗ |
| Clarus Lifesciences III, L.P. | 10% Owner | C Conversion deriv | 2020-07-28 | 2020-07-30 | 2,109,407 | — | $0 | 0 | SEC↗ |
| Clarus Lifesciences III, L.P. | 10% Owner | C Conversion deriv | 2020-07-28 | 2020-07-30 | 5,666,667 | — | $0 | 0 | SEC↗ |
| DEERFIELD PARTNERS, L.P. | 10% Owner | C Conversion | 2020-07-28 | 2020-07-28 | 458,914 | — | $0 | 458,914 | SEC↗ |
| DEERFIELD PARTNERS, L.P. | 10% Owner | C Conversion | 2020-07-28 | 2020-07-28 | 458,914 | — | $0 | 458,914 | SEC↗ |
| DEERFIELD PARTNERS, L.P. | 10% Owner | P Buy | 2020-07-28 | 2020-07-28 | 350,000 | $17.00 | $5.95M | 808,914 | SEC↗ |
| DEERFIELD PARTNERS, L.P. | 10% Owner | P Buy | 2020-07-28 | 2020-07-28 | 350,000 | $17.00 | $5.95M | 808,914 | SEC↗ |
| Satter Muneer A | Director | C Conversion | 2020-07-28 | 2020-07-28 | 1,754,978 | — | $0 | 1,754,978 | SEC↗ |
| Satter Muneer A | Director | P Buy | 2020-07-28 | 2020-07-28 | 200,000 | $17.00 | $3.40M | 1,954,978 | SEC↗ |
| Lew Jennifer | EVP & Chief Financial Office | P Buy | 2020-07-28 | 2020-07-28 | 2,000 | $17.00 | $34.0K | 2,000 | SEC↗ |
| Bain Capital Life Sciences Fun | 10% Owner | P Buy | 2020-07-28 | 2020-07-28 | 400,000 | $17.00 | $6.80M | 3,241,628 | SEC↗ |
| Bain Capital Life Sciences Fun | 10% Owner | C Conversion | 2020-07-28 | 2020-07-28 | 319,243 | — | $0 | 2,841,628 | SEC↗ |
| Bain Capital Life Sciences Fun | 10% Owner | C Conversion | 2020-07-28 | 2020-07-28 | 2,522,385 | — | $0 | 2,522,385 | SEC↗ |
| Redmile Group, LLC | 10% Owner | C Conversion | 2020-07-28 | 2020-07-30 | 1,596,222 | — | $0 | 1,596,222 | SEC↗ |
| Clarus Lifesciences III, L.P. | 10% Owner | P Buy | 2020-07-28 | 2020-07-30 | 200,000 | $17.00 | $3.40M | 2,730,635 | SEC↗ |
| Clarus Lifesciences III, L.P. | 10% Owner | C Conversion | 2020-07-28 | 2020-07-30 | 239,433 | — | $0 | 2,530,635 | SEC↗ |
| Clarus Lifesciences III, L.P. | 10% Owner | C Conversion | 2020-07-28 | 2020-07-30 | 697,860 | — | $0 | 2,291,202 | SEC↗ |
| Clarus Lifesciences III, L.P. | 10% Owner | C Conversion | 2020-07-28 | 2020-07-30 | 950,134 | — | $0 | 1,593,342 | SEC↗ |
| Clarus Lifesciences III, L.P. | 10% Owner | C Conversion | 2020-07-28 | 2020-07-30 | 643,208 | — | $0 | 643,208 | SEC↗ |
| Overdorf Michael | EVP & Chief Business Officer | A Award deriv | 2020-07-23 | 2020-07-24 | 242,905 | — | $0 | 242,905 | SEC↗ |